Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 22 results for "horlicks and boost"

Brand integration boosts kids TV

NEW DELHI: Children's TV channels in India earn as much as 10% of their revenues from brand integrations and there is potential for this sector to grow further, according to industry figures. Nina Jaipuria, evp & business head/Kids Cluster at ... WARC, 4 weeks ago

Ads go rad, but will they help customers loosen the purse strings?

All the chumps who clicked on Anouk's latest 'Bold is Beautiful' advertisement hoping for some girl-on-girl action were in for a surprise. It was, unusually enough, an artful portrayal of a couple (who happened to be lesbian) at a decisive moment in ...
 Economic Times2 weeks ago
Times of India

Ads go rad

From the boss wife to the bold lesbian twosome, it's hard to miss the flood of fem-vertising. But by tugging at your heartstrings, are the lean-in ads simply loosening the purse strings? All the chumps who clicked on Anouk's latest 'Bold is ...
 Times of India2 weeks ago

Maggi adulterated my memory, not food

cytotec online pharmacies acne pills like accutane generic nolvadex buy metformin online enquiry Memory and sentiment often go together. Memory is a sensorium, a vista of smells, sounds, a nostalgia for the touch, taste or texture of an object or ...
 Deccan Chronicle3 weeks ago

India's Sensex fall continues, rupee declines

Mumbai: Indian stocks fell for a fifth day, led by Reliance Industries, as a technical chart signaled more declines are in store for the $1.5 trillion equity market. Reliance, owner of the world's largest refining complex, tumbled the most in four ...
 Times of Oman3 weeks ago Sensex Death Cross Looms as Reliance Leads Fifth Day of Slide  La Repubblica3 weeks ago
Yahoo! UK and Ireland

Why GlaxoSmithKline plc Is More Like Unilever plc Than AstraZeneca plc

It used to be that investors in big pharma had a straight choice between GlaxoSmithKline (LSE: GSK) (NYSE:GSK.US) and AstraZeneca (LSE:AZN) (NYSE: AZN.US). They remain the two largest firms in the pharmaceutical sector of the London Stock Exchange, ...
 Yahoo! UK and Ireland1 month ago

VC firm Elderstreet backs expats network

AngloINFO, a provider of information and support to a global network of English-speaking expats, has secured £400,000 from venture capital firm Elderstreet Investments. The franchise business is headquartered in Oxfordshire and operates more ...
 Insider Media Limited1 month ago Investment Opens Up the World for AngloINFO  Franchiseek1 month ago

Mother's Day After-Math

She's Back Conviction has made no dent in Amma's mass appeal Known to be friendly with Modi, Jaitley and Maneka Gandhi 11 AIADMK MPs in RS crucial for passage of Land bill and GST An AIADMK-BJP alliance appears a distinct possibility DMK, ...
 Outlook India1 month ago

Q4 results: GSK Consumer's sales growth turns weak

High valuations are not unusual for foreign-owned consumer stocks, but low sales growth could make people wonder if it is justified. GlaxoSmithKline (GSK) Consumer Healthcare Ltd's investors shrugged aside slower sales growth in the March ...
 Livemint.com1 month ago

Hold GSK Consumer, target Rs 6,716: Edelweiss

Maintain hold on GSK Consumer Healthcare with a target price of R6,716 a share after marginally increasing our target multiple to 35x FY17e. We continue to like GSK's core business, marked increase in OHC/wellness segment, robust volume growth ...
 Financial Express1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less